Injective MCP server lets AI agents deploy smart contracts with a simple prompt
Imagine telling your AI assistant to deploy a smart contract the same way you’d ask it to book a dinner reservation. That’s essentially what Injective just built.
The blockchain network’s Model Context Protocol (MCP) server enables AI coding agents to build, deploy, and verify smart contracts on Injective using natural language prompts. No manual transaction construction required.
What the MCP server actually does
The MCP server acts as a bridge between AI models and Injective’s onchain modules, converting what an AI agent wants to do into the precise blockchain operations needed to make it happen.
It ships with 22 tools covering market data, trading, transfers, and bridging. The server uses AES-256 encryption for key security.
Injective CEO Eric Chen framed the philosophy behind the launch pretty clearly.
“Agents shouldn’t need to understand transaction construction to trade onchain. With the MCP Server, any AI agent can go from intent to signed trade in seconds.”
The bigger picture: an AI-native blockchain stack
The MCP server isn’t a one-off product launch. It’s part of a growing ecosystem of AI-focused developer resources that Injective has been assembling.
An Injective Documentation MCP server provides example prompts for users, including prompts for deploying EVM smart contracts. Meanwhile, an agent-skills repository includes the injective-evm-developer package, which facilitates EVM smart contract development on the network.
Stitch these pieces together and you get an end-to-end workflow. A coding agent can reference documentation, write a contract, deploy it to the blockchain, and verify it, all through the MCP server tools.
What this means for investors and developers
For traders, the MCP server’s trading tools mean AI agents can execute perpetual futures trades, access market data, and manage transfers autonomously.
The open-source nature of the MCP server is worth noting. By making the tools publicly available, Injective is inviting the broader developer community to build on top of the protocol, audit the code, and extend its capabilities.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
As AI controversies escalate, hedge funds buy tech stocks at the fastest pace in 15 months
Hedge funds have recorded net purchases of US TMT stocks on 10 out of the past 11 trading days, rebuilding tech long positions at the fastest pace in 15 months. However, an AI policy storm has struck at the "worst possible time"—calls by AI giants to slow down development have been rejected, and regulatory uncertainty has directly hit Asian tech stocks such as Softbank. As the tech sector's bullish run coincides with Super Central Bank Week, the sector now faces a severe test.
Apple Pre-sale Tracker: iPhone 18 Pro Series Shows Weak Overseas Demand Signals, Duo Review Positive but Hardware Lags Behind
According to a survey by Jefferies, after the launch of the iPhone 18 Pro, delivery wait times in the four major markets—the US, UK, Germany, and Japan—have shortened by 5 to 11 days compared to last year, with no wait time in the US. Given stable production capacity, this is a clear sign of weak demand. Although the China and Hong Kong markets have performed better against the trend, there are still suspicions of speculative stockpiling. The new foldable Duo has been praised for its software experience, but its $2,000 price tag comes with a 254-gram body and dual-camera setup, leaving its hardware lagging significantly behind Android competitors. Jefferies maintains an "underperform" rating, with a target price implying a 21% downside from the current level.
SUI holds $0.71 support as analysts cite key buy signal, eyes on possible recovery
UBS Health Benefit Survey: Elevance Health (ELV.US) Leads, U.S. Employers Prepare for Rising Medical Costs
In the annual survey by UBS for employee benefits management institutions, Elevance Health (ELV.US) emerged as the highest-rated US health insurance company.

